Join the Epilepsy group to help and get support from people like you.
Epilepsy News (Page 2)
Using Only 'Brain Recordings' From Patients, Scientists Reconstruct a Pink Floyd Song
TUESDAY, Aug. 15, 2023 – The famous Pink Floyd lyrics emerge from sound that is muddy, yet musical: “All in all, it was just a brick in the wall.” But this particular recording didn’t come from the 1...
Maternal Epilepsy Does Not Affect Infant Neurodevelopmental Outcomes
FRIDAY, Aug. 11, 2023 – Children with and without fetal exposure to antiseizure medications have no differences in neurodevelopmental outcomes, although secondary analyses show some...
Study IDs Reference Levels for Serum Neurofilament Light Chain in Youth
TUESDAY, Aug. 8, 2023 – Measures of serum neurofilament light chain (sNfL) clinically differentiate children with neurological conditions versus healthy children, according to a study published...
Here's How to Make Summer Sports Camp a Safe Adventure for Your Kid
WEDNESDAY, July 19, 2023 – If your child is in sports camp this summer, you’ll want them to have fun and stay safe. The National Athletic Trainers’ Association (NATA) offers some tips on dealing wit...
EMS Crews May Not Always Follow Guidelines When Dosing Kids: Study
MONDAY, July 10, 2023 – Less than half of all children treated by emergency medical services receive the right amount of medication during out-of-hospital emergencies, a new study found. In some...
Surgery Offers Survival Benefit for Pediatric Drug-Resistant Epilepsy
TUESDAY, June 20, 2023 – For pediatric patients with drug-resistant epilepsy, vagus nerve stimulation (VNS) or cranial epilepsy surgery offers a survival benefit compared with antiseizure...
Seizures While Driving Highlight Importance of Early Diagnosis of Epilepsy
FRIDAY, June 9, 2023 – Before learning they had epilepsy, about 5% of people who have what's called focal epilepsy had a seizure while driving, new research suggests. “Seizures while driving pose s...
~5 Percent Have Seizure While Driving Prior to Epilepsy Diagnosis
FRIDAY, June 9, 2023 – About 5 percent of people have a seizure while driving (SzWD) prior to being diagnosed with epilepsy, according to a study published online June 7 in Neurology. Benjamin...
Alzheimer's Genes Might Also Raise Odds for Epilepsy
THURSDAY, May 25, 2023 – People with a genetic predisposition to Alzheimer’s disease may have an increased risk of epilepsy, a new study says. And folks with a certain type of epilepsy may have hig...
Causal Link ID'd for Alzheimer Disease, Generalized Epilepsy
THURSDAY, May 25, 2023 – There is a causal link between Alzheimer disease (AD), amyloid pathology, and generalized epilepsy, according to a study published online May 24 in Neurology. Yi Fang, M.D.,...
FDA Approves Zonisade (zonisamide oral suspension) for the Treatment of Partial-Onset Seizures
The first and only FDA-approved zonisamide oral liquid formulation WOBURN, Mass., July 18, 2022 /PRNewswire/ – Azurity Pharmaceuticals, Inc., a private pharmaceutical company focused on developing...
FDA Approves Ztalmy (ganaxolone) for Seizures Associated with CDKL5 Deficiency Disorder
RADNOR, Pa.--(BUSINESS WIRE)-- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today...
FDA Approves Eprontia (topiramate) Oral Solution for Epilepsy and Preventive Treatment of Migraine
WOBURN, MA, November 8, 2021 – Azurity Pharmaceuticals, Inc. a private specialty pharmaceutical company focused on developing innovative products to meet the unique needs of patients with underserved ...
Vimpat (lacosamide) Now Approved by FDA for Primary Generalized Tonic-Clonic Seizures and Expanded Pediatric Use for People Living with Epilepsy
ATLANTA, Nov. 17, 2020 /PRNewswire/ – UCB, a global pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Vimpat (lacosamide) CV as adjunctive therapy...
FDA Approves Valtoco (diazepam nasal spray) as a Seizure Rescue Treatment
SAN DIEGO, CA – January 13, 2020 – Neurelis, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved Valtoco (diazepam nasal spray) as an acute treatment of intermittent, s...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Seizures, Lennox-Gastaut Syndrome
Related drug support groups
gabapentin, Klonopin, clonazepam, Lyrica, Lamictal, lorazepam, diazepam, Topamax, pregabalin, view more... lamotrigine, Depakote, Neurontin, topiramate, Keppra, Trileptal, Tegretol, oxcarbazepine, phenobarbital, levetiracetam, Vimpat